Salamol - Top U.S. Generic Blockbusters

Salamol
Branded drug: Ventolin
U.S. sales: $1 billion

Salamol, or salbutamol, has been around for more than 40 years and is probably the go-to inhaler product for people suffering from asthma. It is still sold under branded names such as Ventolin by GlaxoSmithKline ($GSK) but also is sold by a host of generics makers, like Teva Pharmaceutical Industries ($TEVA) and Cipla. Outside the U.S., there was a little stir this year when the U.K. pharmacy chain Asda began selling the inhalers over the counter to anyone over 16 that completed a questionnaire about their need.

Salamol - Top U.S. Generic Blockbusters
Read more on

Suggested Articles

Pfizer is doubling down on real-world data in HR-positive, HER2-negative breast cancer patients to boost its case for blockbuster Ibrance.

Sanofi, which has moved purposefully into high technologies to get more from its manufacturing, will lean even more on that strategy to save costs.

In a last-minute deal during North American trade talks, the Trump administration agreed to scrap rules protecting biologic drugs from copycat rivals.